Health Catalyst (HCAT) has released an update.
Bryan Hunt is stepping down as CFO of the Company, with a transition period as a senior advisor. His exit includes a severance package with cash, stock units, and extended option exercise. Jason Alger is to take over as CFO, with a salary boost and performance-based incentives, while Daniel LeSueur will become COO, also with a salary increase and similar stock options. Director Mark Templeton resigned without conflict, with an accelerated vesting of his stock units. All appointments and resignations are effective March 1, 2024.
For further insights into HCAT stock, check out TipRanks’ Stock Analysis page.
